Novartis has scrapped a fifth of its programs in pursuit of 'truly impactful' drugs, Bradner reveals
It turns out the wave of global restructuring at Novartis has claimed more than just jobs — it’s also taken a sizable chunk of its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
